Deadly amphibian plague can infect young zebrafish, scientists discover
The deadly chytrid fungus has for the first time been found to infect and kill species other than amphibians, giving clues on how it causes disease.
Breakthrough in 'amphibian plague': deadly fungus genes identified
Scientists have identified the genes of a deadly fungus that is decimating salamander and newt populations in Northern Europe.
2
New stenting tool could make heart procedures cheaper and less painful
A new tool for assessing the narrowing of the heart's arteries was found to be as effective as current methods and less painful for patients.
New 'gene silencer' drug injections reduce cholesterol by 50% in clinical trial
The first in a new class of gene-silencing drugs, known as inclisiran, has halved cholesterol levels in patients at risk of cardiovascular disease.
6
Feature
Imperial early-career scientist dubbed 'broadcaster of the future' by BBC: a Q&A
Dr Daisy Fancourt has been selected to take part in the BBC's 2017 New Generation Thinkers programme.
Video
Robots help people improve at physical tasks in new study
Researchers at Imperial College London have programmed human learning behaviour into robots to help humans complete physical tasks.
Warning signs might have been missed in one in six England heart attack deaths
Heart attack symptoms might have been missed in many patients, according to a study on all heart attack hospital admissions and deaths in England.
1m pound grant to investigate how cultural pursuits affect health and wellbeing
A joint venture between the Royal College of Music and Imperial was awarded £1 million for a new research project on the arts and health.
Artificial intelligence could increase speed and reliability of brain research
Neuroscientists at Imperial have highlighted the benefits of using machine learning techniques in real-time brain imaging studies.
1
Type 2 diabetes prevented in 80 percent of at-risk patients with repurposed drug
A weight loss drug has reduced the risk of type 2 diabetes by 80 per cent compared to placebo.
